Terms: = Ovarian cancer AND ZNF198, Q9UBW7, SCLL, RAMP, MYM, FIM, 7750
45 results:
1. Screening and prevention of ovarian cancer.
Sideris M; Menon U; Manchanda R
Med J Aust; 2024 Mar; 220(5):264-274. PubMed ID: 38353066
[TBL] [Abstract] [Full Text] [Related]
2. Association of pre-diagnosis specific color groups of fruit and vegetable intake with ovarian cancer survival: results from the ovarian cancer follow-up study (OOPS).
Liu YY; Gong TT; Li YZ; Xu HL; Zheng G; Liu FH; Qin X; Xiao Q; Wu QJ; Huang DH; Gao S; Zhao YH
Food Funct; 2023 Sep; 14(18):8442-8452. PubMed ID: 37622277
[No Abstract] [Full Text] [Related]
3. Pathological findings and long-term prognosis in Korean BRCA1/2 mutation carriers undergoing risk-reducing salpingo-oophorectomy.
Kang OJ; Lee SW; Kim JH; Park JY; Suh DS; Kim DY; Kim JH; Kim YM; Kim YT
Int J Gynecol Cancer; 2023 Nov; 33(11):1743-1749. PubMed ID: 37541685
[TBL] [Abstract] [Full Text] [Related]
4. Decision-making for intensive rehabilitation in patients with Trousseau syndrome: Insights from a case series.
Takeshima S; Kawate N
Medicine (Baltimore); 2023 Jun; 102(26):e34097. PubMed ID: 37390272
[TBL] [Abstract] [Full Text] [Related]
5. Risk-reducing salpingo-oophorectomy among Chinese women at increased risk of breast and ovarian cancer.
Feng Z; Zuo K; Ju X; Chen X; Yang W; Wen H; Yu L; Wu X
J Ovarian Res; 2023 Jun; 16(1):125. PubMed ID: 37386498
[TBL] [Abstract] [Full Text] [Related]
6. A questionnaire-based survey on the diagnostic and therapeutic approaches for patients with STIC in Germany.
van der Ven J; Linz VC; Anic K; Schmidt MW; Loewe A; Krajnak S; Schmidt M; Kommoss S; Schmalfeldt B; Sehouli J; Hasenburg A; Battista MJ
Arch Gynecol Obstet; 2023 Aug; 308(2):527-534. PubMed ID: 36707423
[TBL] [Abstract] [Full Text] [Related]
7. Prevalence of precursor lesions (P53 signature, SCOUT, STIL, STIC) in fallopian tubes resected for non-neoplastic causes.
Tewari S; Misra V; Kumar V; Mishra RR; Yadav K; Paridhi ; Sangma H
Indian J Pathol Microbiol; 2022; 65(3):610-616. PubMed ID: 35900489
[TBL] [Abstract] [Full Text] [Related]
8. Anesthetic management of a severely obese patient (body mass index 70.1 kg/m
Yamochi S; Kinoshita M; Sawa T
J Med Case Rep; 2022 Apr; 16(1):164. PubMed ID: 35468828
[TBL] [Abstract] [Full Text] [Related]
9. Recommendations for diagnosing STIC: a systematic review and meta-analysis.
Bogaerts JMA; Steenbeek MP; van Bommel MHD; Bulten J; van der Laak JAWM; de Hullu JA; Simons M
Virchows Arch; 2022 Apr; 480(4):725-737. PubMed ID: 34850262
[TBL] [Abstract] [Full Text] [Related]
10. Efficacy of risk-reducing salpingo-oophorectomy in BRCA1-2 variants and clinical outcomes of follow-up in patients with isolated serous tubal intraepithelial carcinoma (STIC).
Saccardi C; Zovato S; Spagnol G; Bonaldo G; Marchetti M; Alessandrini L; Tognazzo S; Guerriero A; Vitagliano A; Laganà AS; Noventa M
Gynecol Oncol; 2021 Nov; 163(2):364-370. PubMed ID: 34465478
[TBL] [Abstract] [Full Text] [Related]
11. Clinical and pathological outcomes of risk-reducing salpingo-oophorectomy for Japanese women with hereditary breast and ovarian cancer.
Nomura H; Ikki A; Fusegi A; Omi M; Aoki Y; Netsu S; Tanigawa T; Matoda M; Okamoto S; Omatsu K; Nakajima T; Ueki A; Tonooka A; Kanao H
Int J Clin Oncol; 2021 Dec; 26(12):2331-2337. PubMed ID: 34453642
[TBL] [Abstract] [Full Text] [Related]
12. Prevalence of endosalpingiosis and other benign gynecologic lesions.
Sunde J; Wasickanin M; Katz TA; Wickersham EL; Steed DOE; Simper N
PLoS One; 2020; 15(5):e0232487. PubMed ID: 32401810
[TBL] [Abstract] [Full Text] [Related]
13. [The pathology of hereditary ovarian tumors].
Pesce F; Devouassoux-Shisheboran M
Ann Pathol; 2020 Apr; 40(2):85-94. PubMed ID: 32178889
[TBL] [Abstract] [Full Text] [Related]
14. Relationship between the precursors of high grade serous ovarian cancer and patient characteristics: decreased incidence of the p53 signature in pregnant women.
Ida T; Fujiwara H; Kiriu T; Taniguchi Y; Kohyama A
J Gynecol Oncol; 2019 Nov; 30(6):e96. PubMed ID: 31576690
[TBL] [Abstract] [Full Text] [Related]
15. Pathological findings following risk-reducing salpingo-oophorectomy in BRCA mutation carriers: A systematic review and meta-analysis.
Cheng A; Li L; Wu M; Lang J
Eur J Surg Oncol; 2020 Jan; 46(1):139-147. PubMed ID: 31521389
[TBL] [Abstract] [Full Text] [Related]
16. Health Care Provider Adherence to Surgical Guidelines for Risk-Reducing Salpingo-Oophorectomy.
Wilhite AM; Oestreich MC; Olson M; Bedell SM; Westenberg D; Bangdiwala A; Ikramuddin S; Sanchez-Avila M; Madoff RD; Khalifa MA; Erickson BK
Obstet Gynecol; 2019 Sep; 134(3):520-526. PubMed ID: 31403600
[TBL] [Abstract] [Full Text] [Related]
17. Pathology findings and clinical outcomes after risk reduction salpingo-oophorectomy in BRCA mutation carriers: a multicenter Spanish study.
Minig L; Cabrera S; Oliver R; Couso A; Rubio MJ; Iacoponi S; Martin-Salamanca MB; Carballo-Rastrilla S; Cádenas-Rebollo JM; García-Garcia A; Gil-Ibáñez B; Juan-Fita MJ; Patrono MG
Clin Transl Oncol; 2018 Oct; 20(10):1337-1344. PubMed ID: 29623583
[TBL] [Abstract] [Full Text] [Related]
18. Processing of fallopian tube, ovary, and endometrial surgical pathology specimens: A survey of U.S. laboratory practices.
Samimi G; Trabert B; Duggan MA; Robinson JL; Coa KI; Waibel E; Garcia E; Minasian LM; Sherman ME
Gynecol Oncol; 2018 Mar; 148(3):515-520. PubMed ID: 29395311
[TBL] [Abstract] [Full Text] [Related]
19. [Morphologic features of fallopian tubal epithelium in pelvic high-grade serous carcinoma].
Zhao RJ; Wang YY; Li Z; Wu KY; Kong LF; Zheng WX
Zhonghua Bing Li Xue Za Zhi; 2017 Aug; 46(8):542-547. PubMed ID: 28810294
[No Abstract] [Full Text] [Related]
20. Disease Distribution in Low-stage Tubo-ovarian High-grade Serous Carcinoma (HGSC): Implications for Assigning Primary Site and FIGO Stage.
Singh N; Benson JL; Gan C; Anglesio M; Arora R; Faruqi AZ; Hirschowitz L; Kommoss F; Scott K; Trevisan G; Leen SLS; Wilkinson N; Gilks CB; McCluggage WG
Int J Gynecol Pathol; 2018 Jul; 37(4):324-330. PubMed ID: 28787323
[TBL] [Abstract] [Full Text] [Related]
[Next]